Refining the interpretation of drug survival and safety in VEXAS syndrome: the importance of competing risks and exposure time. Comment on the article by Eviatar et al

Documenti analoghi

• Balancing weight reduction benefits and risks: implications for serum urate management. Comment on the article by Fukui et al
  di: Pei Liu, et al.
  Pubblicazione: (2025)
• Long‐term follow‐up of immunogenicity in radiographic axial spondyloarthritis patients: beyond drug survival and tapering. Comment on the article by Clarissa et al
  di: Jin‐Xian Huang, et al.
  Pubblicazione: (2024)
• Potential Confounding by Weight Loss: Comment on the article by Jorge et al.
  di: Eylul Kizkapan, et al.
  Pubblicazione: (2026)
• Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter: comment on the article by Geslin et al
  di: Shiuan‐Chih Chen, et al.
  Pubblicazione: (2025)
• TIPIC syndrome induced by G‐CSF: comment on the article by Namineni et al
  di: Takao Nagashima
  Pubblicazione: (2025)